These innovative medications, like copyright and Semaglutide, represent a significant class of drugs called GLP-1 receptor agonists. They work by enhancing the body's intrinsic ability to release GLP-1, a substance that helps regulate blood sugar and hunger. First and foremost, designed for treating type 2 diabetes, they have also shown effectivene